EXPRESSION OF AGGRECANASE AFFECTED BY CELECOXIB IN SERUM WITH OSTEOARTHRITIS

LIU Yong-Min,FENG Zhi-Ying,GU Peng-Cheng,ZHANG Yan-Feng,LIN Xiang-Jin,ZHU Sheng-Mei
DOI: https://doi.org/10.3969/j.issn.1006-9852.2011.11.012
2011-01-01
Abstract:Objective : To detect the effect of celecoxib on the expression of aggrecanase-1(Agase-1) and tissue inhibitor of metalloproteinase-3(TIMP-3) in the serum of late osteoarthritis(OA) patients.Methods: 39 cases were divided into celecoxib-treated group(n = 21) who received total knee replacement surgery with celecox-ib for 8 weeks and control group(n = 18) of emergency surgery of knee without celecoxib. Celecoxib was given orally twice a day after admission until the day before operation.Expression of Agase-1 and TIMP-3 concentration in the two groups were investigated by enzyme-linked immunosorbent assay(ELISA) and represented by ng/ml.Changes of proteoglycan(PG) in cartilage were analysed by toluidine blue method.Results : Expressions of Agase-1 have no difference between two group(P > 0.05).Compared to control group,the serum levels of TIMP-3 and PG in cartilage in celecoxib-treated group increased significantly(P < 0.01).Conclusion : Celecoxib can increase PG expression in cartilage by upregulation of TIMP-3 which can inhibit Agase-1 activity.
What problem does this paper attempt to address?